Screening for non-alcoholic fatty liver disease in children and adolescents with type 1 diabetes mellitus: a cross-sectional analysis

被引:0
作者
Sebastian Kummer
Dirk Klee
Gerald Kircheis
Michael Friedt
Joerg Schaper
Dieter Häussinger
Ertan Mayatepek
Thomas Meissner
机构
[1] University Children’s Hospital,Department of General Pediatrics, Neonatology and Pediatric Cardiology
[2] University Hospital,Department of Diagnostic and Interventional Radiology, Medical Faculty
[3] University Hospital,Department of Gastroenterology, Hepatology and Infectious Diseases
来源
European Journal of Pediatrics | 2017年 / 176卷
关键词
Diabetes mellitus type 1; Non-alcoholic fatty liver disease; Prevalence; Diabetes complication;
D O I
暂无
中图分类号
学科分类号
摘要
The liver is intensely involved in glucose metabolism and is thereby closely related to diabetes pathophysiology. Adult patients with type 1 diabetes mellitus (DM) are at an increased risk for non-alcoholic fatty liver disease (NAFLD). Here, we studied the prevalence of NAFLD in a cohort of children and adolescents with type 1 DM in a tertiary care paediatric diabetes centre in Germany. We screened 93 children and adolescents with type 1 DM using ultrasound, laboratory investigations, and liver stiffness measurements (Fibroscan® [FS] and acoustic radiation force imaging [ARFI]). Of these, 82 (88.1%) had completely normal results in all examined aspects. Only one patient (1.1%) fulfilled the criteria as potential NAFLD with ALT > twice the upper limit of normal. Ten of the 93 patients (10.8%) showed any mild abnormality in at least one examined category including ALT, conventional ultrasounds and liver stiffness measurements. However, none of these ten fulfilled the NAFLD case definition criteria. Therefore, these slightly abnormal results were judged to be unspecific or at least of unknown significance in terms of NAFLD indication.
引用
收藏
页码:529 / 536
页数:7
相关论文
共 222 条
[1]  
Al-Hussaini AA(2012)Prevalence of hepatopathy in type 1 diabetic children BMC Pediatr 12 160-e117
[2]  
Sulaiman NM(2014)How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound Liver Int 34 e111-17
[3]  
Alzahrani MD(2014)ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents Pediatr Diabetes 15 4-450
[4]  
Alenizi AS(2007)Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy J Pediatr Gastroenterol Nutr 45 443-194
[5]  
Khan M(2016)Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus J Diabetes Complicat 31 186-470
[6]  
Carvalhana S(2010)Prevalence of hepatic abnormalities in a cohort of Egyptian children with type 1 diabetes mellitus Pediatr Diabetes 11 462-360
[7]  
Leitão J(2012)Feasibility study and control values of transient elastography in healthy children Eur J Pediatr 171 353-E222
[8]  
Alves AC(2015)Comparison of the physiological relevance of systemic vs. portal insulin delivery to evaluate whole body glucose flux during an insulin clamp Am J Physiol - Endocrinol Metab 308 E206-357
[9]  
Bourbon M(2014)Hepatopathy of Mauriac syndrome: a retrospective review from a tertiary liver centre Arch Dis Child 99 354-1820
[10]  
Cortez-Pinto H(2007)Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004 Gastroenterology 133 1814-974